Amphastar Pharmaceuticals, Inc.
AMPH
$22.74
-$0.19-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 30.35M | 6.42M | 24.43M | 17.35M | 31.03M |
| Total Depreciation and Amortization | 16.46M | 16.49M | 15.99M | 15.77M | 16.24M |
| Total Amortization of Deferred Charges | 875.00K | 761.00K | 866.00K | 885.00K | 842.00K |
| Total Other Non-Cash Items | 6.22M | 8.86M | 34.31M | 6.58M | 6.01M |
| Change in Net Operating Assets | -2.58M | 15.31M | -42.73M | 12.00M | -18.53M |
| Cash from Operations | 51.32M | 47.84M | 32.86M | 52.58M | 35.59M |
| Capital Expenditure | -8.59M | -9.51M | -8.27M | -5.35M | -10.57M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 53.46M | -7.23M | -52.30M | -14.27M | 9.94M |
| Cash from Investing | 44.87M | -16.73M | -60.57M | -19.62M | -625.00K |
| Total Debt Issued | -- | -- | 273.00K | 172.00K | 4.13M |
| Total Debt Repaid | -525.00K | -29.00K | -104.00K | -44.00K | -37.00K |
| Issuance of Common Stock | 1.52M | -- | 1.98M | 379.00K | 494.00K |
| Repurchase of Common Stock | -44.53M | -30.18M | -20.52M | -4.85M | -34.54M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -8.00K | -4.00K | -253.00K |
| Cash from Financing | -43.54M | -30.21M | -18.37M | -4.35M | -30.20M |
| Foreign Exchange rate Adjustments | 16.00K | -138.00K | -9.00K | -41.00K | 142.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 52.68M | 762.00K | -46.09M | 28.58M | 4.91M |